They identified differential expression of hypoxia and complement system genes in non‐responders, while immune cell, particularly CD8+ T cell, infiltration was higher in responders, suggesting that spatially resolved tumour–immune interactions may contribute to therapy resistance in HNSCC. Here, CD8A is linked to neoplasm.